BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6414105)

  • 1. Distribution and excretion of 2,3,6,2',3',6'- and 2,4,5,2',4',5'-hexachlorobiphenyl in senescent rats.
    Birnbaum LS
    Toxicol Appl Pharmacol; 1983 Sep; 70(2):262-72. PubMed ID: 6414105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The disposition and elimination of two sequential doses of 2,4,5,2',4',5'-hexachlorobiphenyl.
    Gallenberg LA; Vodicnik MJ
    Drug Metab Dispos; 1987; 15(3):363-6. PubMed ID: 2886312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. II. Effects of restricting food intake before and after 6-CB administration.
    Jondorf WR; Wyss PA; Mühlebach S; Bickel MH
    Drug Metab Dispos; 1983; 11(6):597-601. PubMed ID: 6140146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution and excretion of 2,4,5,2',5'-pentachlorobiphenyl in the rat.
    Matthews HB; Anderson MW
    Drug Metab Dispos; 1975; 3(3):211-9. PubMed ID: 238820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue content as a modifier of the tissue distribution, biological effects, and excretion of a hexachlorobiphenyl in C57BL/6J and DBA/JBOMf mice.
    Ahotupa M; Mäntylä E
    Mol Pharmacol; 1983 Nov; 24(3):464-70. PubMed ID: 6415400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. I. Effects of restricting food intake two weeks after administration of 6-CB.
    Wyss PA; Mühlebach S; Bickel MH
    Drug Metab Dispos; 1982; 10(6):657-61. PubMed ID: 6130918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexabromonaphthalene contaminants of polybrominated biphenyls: chemical composition and disposition in the rat.
    Birnbaum LS; Darcey DJ; McKinney JD
    J Toxicol Environ Health; 1983; 12(4-6):555-73. PubMed ID: 6321745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics in rats of 2,4,5,2',4',5'-hexachlorobiphenyl, an unmetabolizable lipophilic model compound.
    Mühlebach S; Bickel MH
    Xenobiotica; 1981 Apr; 11(4):249-57. PubMed ID: 6795836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chlorination on the distribution and excretion of polychlorinated biphenyls.
    Mathews HB; Anderson MW
    Drug Metab Dispos; 1975; 3(5):371-80. PubMed ID: 241618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution, metabolism, and excretion of 2,4,4'-trichlorobiphenyl (CB-28) in the rat.
    Moir D; Viau A; Chu I; Wehler EK; Mörck A; Bergman A
    Toxicol Ind Health; 1996; 12(1):105-21. PubMed ID: 8713718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and biliary excretion of 2,4,5,2',4',5'-hexachlorobiphenyl in the rhesus monkey (Macaca mulatta).
    Norback DH; Mack E; Reddy G; Britt J; Hsia MT
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):71-85. PubMed ID: 6794118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of 1,2,3,7,8-pentachlorodibenzofuran in the rat.
    Brewster DW; Birnbaum LS
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):490-8. PubMed ID: 3188012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of chlorine substitution on the disposition of polychlorinated biphenyls following dermal administration.
    Garner CE; Demeter J; Matthews HB
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):157-67. PubMed ID: 16784763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of chlorine position on the distribution and excretion of four hexachlorobiphenyl isomers.
    Matthews HB; Tuey DB
    Toxicol Appl Pharmacol; 1980 May; 53(3):377-88. PubMed ID: 6770494
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue distribution metabolism and excretion of 2,2',4,4',5-pentachlorodiphenyl ether in the rat.
    Komsta E; Chu I; Villeneuve DC; Benoit FM; Murdoch D
    Arch Toxicol; 1988; 62(4):258-62. PubMed ID: 3149180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term pharmacokinetics of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with constant adipose tissue mass.
    Wyss PA; Mühlebach S; Bickel MH
    Drug Metab Dispos; 1986; 14(3):361-5. PubMed ID: 2872039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disposition and the liver and thymus gland toxicity of 3,3',4,4'-tetrachlorobiphenyl in the female rat.
    Clarke DW; Brien JF; Racz WJ; Nakatsu K; Marks GS
    Can J Physiol Pharmacol; 1984 Oct; 62(10):1253-60. PubMed ID: 6439399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of 2,2',3,3',6,6'-hexachlorobiphenyl and 2,2',4,4',5,5'-hexachlorobiphenyl by human hepatic microsomes.
    Schnellmann RG; Putnam CW; Sipes IG
    Biochem Pharmacol; 1983 Nov; 32(21):3233-9. PubMed ID: 6416258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of hexachlorobenzene in male beagles. Distribution, excretion, and pharmacokinetic model.
    Sundlof SF; Hansen LG; Koritz GD; Sundlof SM
    Drug Metab Dispos; 1982; 10(4):371-81. PubMed ID: 6126337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.